Jaguar Health Inc (NASDAQ:JAGX) Stock Attempts To Recover After The Recent Fall
A wholly-owned subsidiary of Jaguar Health Inc (NASDAQ:JAGX), Napo Pharmaceuticals, on August 23, 2021, announced an abstract related to an exploratory clinical study. It delves into the impact of crofelemer on the gastrointestinal microbiome in people suffering from AIDS and has been given for presentation consideration at IDWeek 2021, taking place virtually from September 29 to October 3. Mytesi (crofelemer), an antidiarrheal drug for the relief of noninfectiousdiarrhea in adults…